SCHEMBL6093641

SCHEMBL6093641

O=C1CCCN1c1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMG1 Q96Q15 9/20 0.66
CDK1 P06493 5/20 0.66
CDK2 P24941 5/20 0.66
CAMK2D Q13557 6/20 0.60
ABL1 P00519 1/20 0.57
BCR P11274 1/20 0.57
PRKCA P17252 1/20 0.57
PRKCD Q05655 1/20 0.57
CSNK2A1 P68400 2/20 0.55
MTOR P42345 4/20 0.53
MAPT P10636 2/20 0.53
NPC1 O15118 1/20 0.53
CCNT1 O60563 1/20 0.53
CDK4 P11802 1/20 0.53
CCNB1 P14635 1/20 0.53
XBP1 P17861 1/20 0.53
CCNA2 P20248 1/20 0.53
CCND1 P24385 1/20 0.53
CCNE1 P24864 1/20 0.53
MAPK1 P28482 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6093874 0.84 SMG1 (0.69) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL5629193 0.83 SMG1 (0.63) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL5629124 0.82 SMG1 (0.61) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL5628905 0.82 SMG1 (0.60) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL6096290 0.81 SMG1 (0.59) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL5629145 0.80 CDK2 (0.61) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL6608384 0.80 SMG1 (0.69) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL6097654 0.80 SMG1 (0.61) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL5630619 0.80 SMG1 (0.58) SMG1CDK1CDK2CAMK2DABL1
SCHEMBL5629180 0.80 SMG1 (0.63) SMG1CDK1CDK2CAMK2DABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100374434-C Microbiocidal N-Phenyl-N-[4-pyridyl-pyrimidin-2-yl]-amine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2008-03-12 CN claimed
US-7074787-B2 Microbiocidal N-phenyl-N-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives SYNGENTA CROP PROTECTION, INC. (US) 2006-07-11 US claimed
EP-1349849-B1 MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2004-09-15 EP claimed
US-20040063937-A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives SYNGENTA CROP PROTECTION, INC. 2004-04-01 US claimed
CN-1484641-A Microbicidal N-phenyl-N- [ 4- (4-pyridyl-2-pyrimidin-2-yl) -amine derivatives ���﹫˾ 2004-03-24 CN claimed
EP-1349849-A1 MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES Syngenta Participations AG (CH) 2003-10-08 EP claimed
WO-2002053560-A1 MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2002-07-11 WO claimed
CN-100374434-C Microbiocidal N-Phenyl-N-[4-pyridyl-pyrimidin-2-yl]-amine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2008-03-12 CN disclosed
US-7074787-B2 Microbiocidal N-phenyl-N-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives SYNGENTA CROP PROTECTION, INC. (US) 2006-07-11 US disclosed
EP-1349849-B1 MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2004-09-15 EP disclosed
US-20040063937-A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives SYNGENTA CROP PROTECTION, INC. 2004-04-01 US disclosed
CN-1484641-A Microbicidal N-phenyl-N- [ 4- (4-pyridyl-2-pyrimidin-2-yl) -amine derivatives ���﹫˾ 2004-03-24 CN disclosed
EP-1349849-A1 MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL)-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES Syngenta Participations AG (CH) 2003-10-08 EP disclosed
WO-2002053560-A1 MICROBIOCIDAL N-PHENYL-N-[4-(4-PYRIDYL-2-PYRIMIDIN-2-YL]-AMINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2002-07-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063937-A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives CCR8, MSR1, TLR8 SMG1 1019/4885CDK1 4719/4885CDK2 4694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.